RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      최신임상강좌 : HPV의 자연사와 자궁경부암의 발암기전 = Recent Clinical Review : Natural history of HPV and carcinogenesis of cervical cancer

      한글로보기

      https://www.riss.kr/link?id=A5041095

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Human Papilloma Virus (HPV) infection is most important in the carcinogenesis of the cervical cancer. More than 100 types of HPV have been identified, among which 15 subtypes were revealed to be related with cervical cancers. Ninety percent of these high-risk HPV infections are removed naturally within 1-2 years, however, women with persistent infection have more than 100 times higher risk of developing cervical intraepithelial neoplasia, the precursor of cervical cancers. In high-risk HPV infection, the integration of viral DNA into host DNA results in the overexpression of E6 and E7 genes. The E6, E7 oncoproteins interfere with the function of tumor suppressor genes, p53 and pRb resulting in the abnormal cell proliferation. In order to diagnose HPV infections, Hybrid Capture II(TM) (Microplate System, Digene, USA) with FDA approval is most widely used, and the DNA chip method developed in Korea is expected to be useful for identification of subtypes in the future. HPV vaccines have been developed for the prevention of HPV infection. Recently, the quadrivalent HPV 6, 11 16, 18 vaccine of Merk and the bivalent HPV 16, 18 vaccine of GSK, are shown to be effective to prevent persistent HPV infection and cytologic abnormality. In order to improve the efficacy of HPV vaccines, it is necessary to set up national recommendations, regarding vaccine groups, the age of vaccination, tests before and after vaccination and the need for catch-up vaccine.
      번역하기

      Human Papilloma Virus (HPV) infection is most important in the carcinogenesis of the cervical cancer. More than 100 types of HPV have been identified, among which 15 subtypes were revealed to be related with cervical cancers. Ninety percent of these h...

      Human Papilloma Virus (HPV) infection is most important in the carcinogenesis of the cervical cancer. More than 100 types of HPV have been identified, among which 15 subtypes were revealed to be related with cervical cancers. Ninety percent of these high-risk HPV infections are removed naturally within 1-2 years, however, women with persistent infection have more than 100 times higher risk of developing cervical intraepithelial neoplasia, the precursor of cervical cancers. In high-risk HPV infection, the integration of viral DNA into host DNA results in the overexpression of E6 and E7 genes. The E6, E7 oncoproteins interfere with the function of tumor suppressor genes, p53 and pRb resulting in the abnormal cell proliferation. In order to diagnose HPV infections, Hybrid Capture II(TM) (Microplate System, Digene, USA) with FDA approval is most widely used, and the DNA chip method developed in Korea is expected to be useful for identification of subtypes in the future. HPV vaccines have been developed for the prevention of HPV infection. Recently, the quadrivalent HPV 6, 11 16, 18 vaccine of Merk and the bivalent HPV 16, 18 vaccine of GSK, are shown to be effective to prevent persistent HPV infection and cytologic abnormality. In order to improve the efficacy of HPV vaccines, it is necessary to set up national recommendations, regarding vaccine groups, the age of vaccination, tests before and after vaccination and the need for catch-up vaccine.

      더보기

      참고문헌 (Reference)

      1 "The promise of global cervical-cancer prevention" 353 : 2101-2104, 2005

      2 "The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix" 224-35,

      3 "The Bethesda system for cervical/ vaginal cytologic diagnosis" 22-7, clinobstetgynecol1992

      4 "The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis" 931-4, jama1989

      5 "Sustained efficacy up to 4 5years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18 follow-up from a randomized control trial" 1247-55, lancetoncol2006

      6 "Re-examination of biopsies taken prior to the development of invasive carcinoma of the cervix Proceedings of the Third National Cancer Conference" JB Lippincott 1956

      7 "Rational use of cryosurgery and cold knife conization for treatment of cervical intraepithelial neoplasia" 507-13, eurjgynaecoloncol1992

      8 "Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine" 96 : 604-615, 2004

      9 "Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic" 293-302, jinfectdis1989

      10 "Pregnancy outcome after loop excision of the cervical transformation zone" 620-5, amjobstetgynecol1993

      1 "The promise of global cervical-cancer prevention" 353 : 2101-2104, 2005

      2 "The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix" 224-35,

      3 "The Bethesda system for cervical/ vaginal cytologic diagnosis" 22-7, clinobstetgynecol1992

      4 "The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis" 931-4, jama1989

      5 "Sustained efficacy up to 4 5years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18 follow-up from a randomized control trial" 1247-55, lancetoncol2006

      6 "Re-examination of biopsies taken prior to the development of invasive carcinoma of the cervix Proceedings of the Third National Cancer Conference" JB Lippincott 1956

      7 "Rational use of cryosurgery and cold knife conization for treatment of cervical intraepithelial neoplasia" 507-13, eurjgynaecoloncol1992

      8 "Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine" 96 : 604-615, 2004

      9 "Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic" 293-302, jinfectdis1989

      10 "Pregnancy outcome after loop excision of the cervical transformation zone" 620-5, amjobstetgynecol1993

      11 "Precancerous lesions of the cervix" New York: Springer-Verlag 7 : 229-277, 1995

      12 "Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia" 57 : 286-293, 1995

      13 "Natural history of cervical intraepithelial neoplasia" intjgynecolpathol1993186-92

      14 "Mechanisms of genomic unstability in human cancer insights from studies with human papillomavirus oncoproteins" 109 : 157-162, 2004

      15 "How will HPV vaccines affect cervical cancer?" 6 : 753-763, 2006

      16 "Globocan 2002" IARC Press 2004

      17 "Electro-conization with the diathermic loop" 53-9, contraceptfertilsex1994

      18 "Diagnosis and treatment of cervical dysplasia report of 42 case" 87-93, revfrgynecolobstet1990

      19 "Complications of cervical cryotherapy in adolescents" 711-6, jreprodmed1991

      20 "Colposcopic manifestayions of cervical and vaginal infections" 373-81, obstetgynecolsurv1988

      21 "Clinical and histological studies on cervical carcinoma" 143 13-6, actapatholmicrobiolscand1960

      22 "Carcinoma in situ contrasted with benign penetrating epithelium" 1670-4, jama1932

      23 "Behavior of mild cervical dysplasia during long-term follow-up" 665-9, obstetgynecol1986

      24 "Behavior of mild cervical dysplasia during long-term follow-up" 609-14, obstetgynecol1983

      25 "2004, Systemic review of genomic integration sites of human papillomavirus geno-mes in epithelial dysplasia and invasive cancer of the female lower genital tract" 64 : 3878-3884, 2004

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2013-01-10 학술지명변경 한글명 : Korean Journal of Obstetrics and Gynecology -> Obstetrics & Gynecology Science
      외국어명 : Korean Journal of Obstetrics and Gynecology -> Obstetrics & Gynecology Science
      KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2011-01-15 학술지명변경 한글명 : 대한산부인과학회지 -> Korean Journal of Obstetrics and Gynecology KCI등재
      2010-06-14 학술지명변경 한글명 : 대한산부인과학회잡지 -> 대한산부인과학회지 KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-05-24 학회명변경 영문명 : 미등록 -> Korean Soceity of Obstetrics and Gynecology KCI등재후보
      2005-03-22 학술지등록 한글명 : 대한산부인과학회잡지
      외국어명 : Korean Journal of Obstetrics and Gynecology
      KCI등재후보
      2005-01-01 평가 등재후보학술지 유지 (등재후보2차) KCI등재후보
      2004-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.04 0.04 0.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.06 0.06 0.255 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼